ArticleBreast cancer research and treatment2024

Long-term prospective outcome data using EndoPredict as risk stratification and chemotherapy decision biomarker in hormone receptor-positive, HER2-negative early breast cancer.

Evelyn Klein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.